Neuropeptides: Potential neuroprotective agents in ischemic injury

P Saklani, H Khan, S Gupta, A Kaur, TG Singh - Life Sciences, 2022 - Elsevier
Aim Ischemic damage to the brain is linked to an increased rate of morbidity and mortality
worldwide. In certain parts of the world, it remains a leading cause of mortality and the …

Review on the protective effects of PACAP in models of neurodegenerative diseases in vitro and in vivo

D Reglodi, P Kiss, A Lubics… - Current pharmaceutical …, 2011 - ingentaconnect.com
Pituitary adenylate cyclase activating polypeptide (PACAP) is a pleiotropic and
multifunctional peptide exerting its effects via 3 main receptors (PAC1, VPAC1 and VPAC2) …

Tunable surface charge enables the electrostatic adsorption-controlled release of neuroprotective peptides from a hydrogel–nanoparticle drug delivery system

E Ho, Y Deng, D Akbar, K Da… - … Applied Materials & …, 2022 - ACS Publications
We exploit the electrostatic interactions between the positively charged neuroprotective
peptide, pituitary adenylate cyclase-activating polypeptide (PACAP), and negatively charged …

Protective effects of PACAP in peripheral organs

D Toth, E Szabo, A Tamas, T Juhasz… - Frontiers in …, 2020 - frontiersin.org
Pituitary adenylate cyclase activating polypeptide (PACAP) is a neuropeptide widely
distributed in the nervous system, where it exerts strong neuroprotective effects. PACAP is …

VIP and PACAP: recent insights into their functions/roles in physiology and disease from molecular and genetic studies

TW Moody, T Ito, N Osefo… - Current Opinion in …, 2011 - journals.lww.com
PACAP/VIP as well as their three classes of receptors are important in many physiological/
pathophysiological processes, some of which are identified in these studies using knockout …

PACAP is an endogenous protective factor—insights from PACAP-deficient mice

D Reglodi, P Kiss, K Szabadfi, T Atlasz… - Journal of Molecular …, 2012 - Springer
Pituitary adenylate cyclase-activating polypeptide (PACAP) is a widespread neuropeptide
with a diverse array of biological functions. Not surprisingly, the lack of endogenous PACAP …

Delayed pituitary adenylate cyclase–activating polypeptide delivery after brain stroke improves functional recovery by inducing M2 microglia/macrophage polarization

C Brifault, M Gras, D Liot, V May, D Vaudry, O Wurtz - Stroke, 2015 - Am Heart Assoc
Background and Purpose—Until now, except thrombolysis, the therapeutical strategies
targeting the acute phase of cerebral ischemia have been proven ineffective, and no …

Protective effects of PACAP in ischemia

D Reglodi, A Vaczy, E Rubio-Beltran… - The Journal of …, 2018 - Springer
Pituitary adenylate cyclase activating polypeptide (PACAP) is an ubiquitous peptide
involved, among others, in neurodevelopment, neuromodulation, neuroprotection …

PACAP as a neuroprotective factor in ischemic neuronal injuries

S Shioda, T Nakamachi - Peptides, 2015 - Elsevier
Pituitary adenylate cyclase-activating polypeptide (PACAP) is a 27-or 38-amino acid
neuropeptide, which belongs to the vasoactive intestinal polypeptide/glucagon/secretin …

Pituitary adenylate cyclase-activating polypeptide: focus on structure-activity relationships of a neuroprotective peptide

S Bourgault, D Vaudry, A Dejda… - Current medicinal …, 2009 - ingentaconnect.com
Pituitary adenylate cyclase-activating polypeptide (PACAP) is a 38-amino acid peptide that
was initially isolated from hypothalamus extracts on the basis of its ability to stimulate the …